论文信息 - Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial - 字舞流文

Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial

N. Munshi | P. Richardson | M. Faham | B. Drénou | P. Moreau | H. Avet-Loiseau | M. Macro | X. Leleu | G. Marit | J. Corre | T. Facon | N. Robillard | B. Arnulf | M. Attal | B. Royer | L. Garderet | L. Karlin | M. Tiab | F. Orsini-Piocelle | S. Bréchignac | K. Belhadj | C. Hulin | L. Benboubker | V. Lauwers-Cances | T. Lamy | M. Chrétien | C. Gentil | K. Anderson